Introduction
Meta-analysis is a valuable tool in evidence-based medicine and research, allowing for the synthesis of data from multiple studies to provide more robust conclusions (1). Traditionally, study-level meta-analysis has been the go-to method for pooling data from different studies to determine the overall effect of a treatment or intervention, as it has a well-defined research question, including clear eligibility criteria concerning participants, interventions, comparisons, and outcomes (2).
However, a newer approach called individual participant data (IPD) meta-analysis is gaining attention because of its distinct advantages. In this editorial, we aim to outline the benefits and drawbacks of using an IPD meta-analysis as opposed to the traditional study-level meta-analysis in the diagnostic imaging field.
What Is IPD Meta-Analysis?
IPD meta-analysis takes a more granular approach by obtaining raw participant-level data from each study included in the analysis. This means that instead of relying solely on aggregated data, researchers have access to the individual data points of each participant (3). This approach allows for more detailed and accurate analyses, as it eliminates the need to rely on summary statistics provided by the original studies. By combining IPD, researchers can explore a wide range of research questions that may not be feasible with study-level meta-analysis alone. This includes the ability to examine subgroup effects, adjust for individual participant characteristics, and conduct more sophisticated statistical analyses (3,4).
IPD meta-analysis is important in radiology for several reasons. First, it allows for the exploration of heterogeneity across studies in depth, providing comprehension of differential treatment effects and diagnostic accuracy. The use of IPD facilitates subgroup analyses based on patient characteristics and imaging techniques, contributing to personalized radiologic interventions. Moreover, IPD meta-analysis emphasizes the clinical relevance of findings, leading to more clinically meaningful analyses and interpretations. By providing robust conclusions, IPD meta-analysis in radiology informs evidence-based practice and guideline development, influencing clinical decision-making and patient management. Ultimately, this approach contributes to advancements in radiologic practice and patient care, making it an important tool for driving progress in the field of radiology.
In Tables 1 and 2, we present a comprehensive summary and description of the key advantages and limitations associated with IPD meta-analysis and conventional study-level meta-analysis in the context of radiology. These tables aim to provide a succinct yet comprehensive overview, aiding researchers and practitioners in navigating the nuanced landscape of meta-analysis methods in the field.
Table 1:
Summary of Benefits and Disadvantages of Individual Participant Data Meta-Analysis in Radiology
Table 2:
Summary of Benefits and Disadvantages of Conventional Study-level Meta-Analysis in Radiology
Regulatory Decision-making: Navigating the Choice between IPD Meta-Analysis and Conventional Study-level Meta-Analysis in Radiology
IPD meta-analysis has distinct advantages in regulatory decision-making, particularly in providing detailed insights into the precision of diagnostic accuracy and the performance of imaging modalities. The improved detail in reliability estimates derived from IPD can offer regulatory bodies a more comprehensive understanding of the nuances associated with different patient groups and clinical situations (8).
On the other hand, conventional study-level meta-analysis may be more practical when IPD are not accessible, as it can still provide valuable insights by synthesizing aggregated study results. Regulatory decision makers must weigh the benefits of IPD meta-analysis in terms of enhanced precision and thoroughness against the potential practical challenges and resource implications it may present, as compared with the more accessible but potentially less detailed conventional study-level meta-analysis.
Conclusion
In the field of radiology, the choice between IPD meta-analysis and conventional study-level meta-analysis involves careful consideration of the advantages and disadvantages offered by each approach. However, IPD meta-analysis provides enhanced precision, opportunities for detailed subgroup analyses, and standardization of analysis methods, including resource intensiveness, data privacy concerns, and potential data heterogeneity. Nevertheless, study-level meta-analysis offers accessibility and ease of data integration, but it may limit the control of analysis methods and hinder the exploration of detailed subgroup analyses in diagnostic imaging.
Footnotes
Authors declared no funding for this work.
Disclosures of conflicts of interest: A.L.F.C. No relevant relationships. S.L.P.C.L. No relevant relationships.
References
- 1. Haidich AB . Meta-analysis in medical research . Hippokratia 2010. ; 14 ( Suppl 1 ): 29 – 37 . [PMC free article] [PubMed] [Google Scholar]
- 2. Fagard RH , Staessen JA , Thijs L . Advantages and disadvantages of the meta-analysis approach . J Hypertens 1996. ; 14 ( Suppl 2 ): S9 – S13 . [DOI] [PubMed] [Google Scholar]
- 3. Tudur Smith C , Marcucci M , Nolan SJ , et al . Individual participant data meta-analyses compared with meta-analyses based on aggregate data . Cochrane Libr 2016. ; 9 ( 9 ): MR000007 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Stewart LA , Tierney JF . To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data . Eval Health Prof 2002. ; 25 ( 1 ): 76 – 97 . [DOI] [PubMed] [Google Scholar]
- 5. Riley RD , Lambert PC , Abo-Zaid G . Meta-analysis of individual participant data: rationale, conduct, and reporting . BMJ 2010. ; 340 ( feb05 1 ): c221 . [DOI] [PubMed] [Google Scholar]
- 6. Zwahlen M , Renehan A , Egger M . Meta-analysis in medical research: potentials and limitations . Urol Oncol 2008. ; 26 ( 3 ): 320 – 329 . [DOI] [PubMed] [Google Scholar]
- 7. Walker E , Hernandez AV , Kattan MW . Meta-analysis: Its strengths and limitations . Cleve Clin J Med 2008. ; 75 ( 6 ): 431 – 439 . [DOI] [PubMed] [Google Scholar]
- 8. Veroniki AA , Seitidis G , Tsivgoulis G , Katsanos AH , Mavridis D . An introduction to individual participant data meta-analysis . Neurology 2023. ; 100 ( 23 ): 1102 – 1110 . [DOI] [PMC free article] [PubMed] [Google Scholar]


